NGF and osteoarthritis: Anti-NGF antibody drugs include Pfizer/Lilly’s Tanezumab and Regeneron/Tiva’s Fasinumab, both of which have achieved significant efficacy in the treatment of moderate to severe osteoarthritis and chronic lower back pain.